Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Choosing between equal and cap weight depends on goals and risk tolerance. This quick guide compares the two for retirement suitability.
24,468 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
A new Roundhill ETF is turning heads with a heavyweight position in Micron Technology. This article explains what the...
When a Planet Labs CEO sells shares, investors take note. This article breaks down what the move could signal, how to...
IonQ faces a pivotal year as government and enterprise demand grows for quantum hardware and software. Analysts outli...
When a top Remitly executive sells shares, investors want to know what it means. This guide explains insider sales, h...
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
The S&P 500’s top ten names now control a record share of the index, a dynamic that could ripple into Bitcoin and the...
A wave of new positions from hedge funds loading boeing points to a cautious but growing bet that Boeing can rebound ...
SpaceX has not announced an IPO date, but growing chatter centers on whether retail investors could drive a future pu...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Bitcoin, XRP, Ethereum, and Solana have all declined 6-8% over the past week, dragging the crypto market lower amid E...
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...